HomeCompareMACK vs DVY

MACK vs DVY: Dividend Comparison 2026

MACK yields 99.70% · DVY yields 3.50%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MACK wins by $3.82M in total portfolio value
10 years
MACK
MACK
● Live price
99.70%
Share price
$15.15
Annual div
$15.10
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.85M
Annual income
$1,294,525.08
Full MACK calculator →
DVY
DVY
● Live price
3.50%
Share price
$150.03
Annual div
$5.25
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.1K
Annual income
$437.78
Full DVY calculator →

Portfolio growth — MACK vs DVY

📍 MACK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMACKDVY
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MACK + DVY cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MACK pays
DVY pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MACK
Annual income on $10K today (after 15% tax)
$8,474.74/yr
After 10yr DRIP, annual income (after tax)
$1,100,346.32/yr
DVY
Annual income on $10K today (after 15% tax)
$297.17/yr
After 10yr DRIP, annual income (after tax)
$372.11/yr
At 15% tax rate, MACK beats the other by $1,099,974.21/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MACK + DVY for your $10,000?

MACK: 50%DVY: 50%
100% DVY50/50100% MACK
Portfolio after 10yr
$1.94M
Annual income
$647,481.43/yr
Blended yield
33.43%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MACK right now

MACK
Analyst Ratings
6
Buy
4
Hold
1
Sell
Consensus: Buy
Altman Z
5.0
Piotroski
2/9
DVY
No analyst data
Altman Z
307.5
Piotroski
1/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MACK buys
0
DVY buys
0
No recent congressional trades found for MACK or DVY in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMACKDVY
Forward yield99.70%3.50%
Annual dividend / share$15.10$5.25
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$3.85M$25.1K
Annual income after 10y$1,294,525.08$437.78
Total dividends collected$3.44M$4.0K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: MACK vs DVY ($10,000, DRIP)

YearMACK PortfolioMACK Income/yrDVY PortfolioDVY Income/yrGap
1← crossover$20,670$9,970.29$11,050$349.62+$9.6KMACK
2$41,378$19,260.63$12,184$361.04+$29.2KMACK
3$80,308$36,033.62$13,409$372.07+$66.9KMACK
4$151,290$65,360.39$14,730$382.68+$136.6KMACK
5$276,955$115,075.35$16,154$392.89+$260.8KMACK
6$493,221$196,878.70$17,688$402.69+$475.5KMACK
7$855,424$327,677.50$19,338$412.07+$836.1KMACK
8$1,446,436$531,132.26$21,113$421.04+$1.43MMACK
9$2,387,024$839,337.57$23,020$429.61+$2.36MMACK
10$3,848,641$1,294,525.08$25,070$437.78+$3.82MMACK

MACK vs DVY: Complete Analysis 2026

MACKStock

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Full MACK Calculator →

DVYETF

The iShares Select Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full DVY Calculator →
📬

Get this MACK vs DVY comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MACK vs SCHDMACK vs JEPIMACK vs OMACK vs KOMACK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.